World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
17307
World Ranking
1937
National Ranking
945

Medicine

D-Index
76
Citations
17279
World Ranking
18921
National Ranking
9431

Overview

Robert H. Wiltrout is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on the fields of Biochemistry, Genetics, and Molecular Biology, contributing to a total of three publications within these domains.

The scientist has concentrated their work on subfields such as Cancer Research and Molecular Biology, with two publications relating to cancer research and one to molecular biology. Their main topics of study include Cancer, Lipids, and Metabolism; Metabolomics and Mass Spectrometry Studies; and Cancer, Hypoxia, and Metabolism, with two publications covering each of these topics.

Among recent publications, Robert H. Wiltrout authored a paper titled "Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma", published in 2021 in the journal Scientific Reports.

Frequent coauthors of Robert H. Wiltrout include:

  • Yotsawat Pomyen
  • Anuradha Budhu
  • Jittiporn Chaisaingmongkol
  • Marshonna Forgues
  • Hien Dang

Scientific Reports is the primary venue for their published work, with one publication in this journal.

Best Publications

  • Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis

    Mark J. Smyth;Erika Cretney;Kazuyoshi Takeda;Robert H. Wiltrout

  • Loss of T-Cell Receptor ζ Chain and p56lck in T-Cells Infiltrating Human Renal Cell Carcinoma

    James H. Finke;Arnold H. Zea;Jill Stanley;Dan L. Longo

  • Role of NK cells in the control of metastatic spread and growth of tumor cells in mice

    E. Gorelik;R. H. Wiltrout;K. Okumura;S. Habu

  • IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

    Tomoaki Hoshino;Robert H. Wiltrout;Howard A. Young

  • The CD95 receptor: apoptosis revisited.

    Marcus E. Peter;Ralph C. Budd;Julie Desbarats;Stephen M. Hedrick

  • Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma

    Jittiporn Chaisaingmongkol;Jittiporn Chaisaingmongkol;Anuradha Budhu;Hien Dang;Siritida Rabibhadana

  • Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

    Shivaani Kummar;Robert Kinders;Martin E. Gutierrez;Larry Rubinstein

  • Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

    T Barlozzari;J Leonhardt;R H Wiltrout;R B Herberman

  • Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

    R. H. Wiltrout;R. B. Herberman;Shu-Ren Zhang;M. A. Chirigos

  • The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

    Jeffrey E Green;Masa-Aki Shibata;Katsuhide Yoshidome;Min-ling Liu

  • Immunotherapy of cancer by IL-12-based cytokine combinations.

    Jonathan M Weiss;Jeff J Subleski;Jon M Wigginton;Robert H Wiltrout

  • Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

    William J Murphy;Lisbeth A. Welniak;Dennis D. Taub;Robert H. Wiltrout

  • Compressing drug development timelines in oncology using phase '0' trials.

    Shivaani Kummar;Robert Kinders;Larry Rubinstein;Ralph E. Parchment

  • In vivo administration of IL‐18 can induce IgE production through Th2 cytokine induction and up‐regulation of CD40 ligand (CD154) expression on CD4+ T cells

    Tomoaki Hoshino;Hideo Yagita;John R. Ortaldo;Robert H. Wiltrout

  • Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

    Robert H. Wiltrout;Bonnie J. Mathieson;James E. Talmadge;Craig W. Reynolds

  • Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood

    Xin Chen;Jeffrey J. Subleski;Ryoko Hamano;O. M. Zack Howard

  • IFN-γ mediates CD4 + T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy

    Vanessa Berner;Haiyan Liu;Qing Zhou;Kory L Alderson

  • Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth.

    Paritosh Ghosh;Kristin L. Komschlies;Marco Cippitelli;Dan L. Longo

  • Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice

    James E. Talmadge;Henry R. Tribble;Robin W. Pennington;Hamblin Phillips

  • Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal Carcinoma

    Jon M. Wigginton;Kristin L. Komschlies;Timothy C. Back;José L. Franco

Frequent Co-Authors

John R. Ortaldo
John R. Ortaldo National Institutes of Health
William J. Murphy
William J. Murphy Texas A&M University
Dan L. Longo
Dan L. Longo Harvard University
Jon M. Wigginton
Jon M. Wigginton Bristol-Myers Squibb (Germany)
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Thomas J. Sayers
Thomas J. Sayers Leidos (United States)
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
Howard A. Young
Howard A. Young National Institutes of Health
Francis W. Ruscetti
Francis W. Ruscetti National Institutes of Health
Dennis D. Taub
Dennis D. Taub George Washington University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various advanced healthcare careers, many of which intersect with nursing specialties. For professionals already in nursing, transitioning to specialized roles such as an Acute Care Nurse Practitioner can be streamlined through options like the fnp to acute care np bridge program. This pathway helps expand expertise in patient care, especially for immunocompromised individuals.

For those starting their healthcare education, accelerated options are available. The accelerated np programs cater to individuals with prior degrees seeking to fast-track their Nurse Practitioner credentials, a vital role in disease management and immunology-related care.

Non-nurses interested in entering the healthcare field may consider foundational programs such as online adn programs for non nurses. These degrees provide essential knowledge and clinical skills relevant to immunology and patient care.

Career advancement in nursing specialties often correlates with remuneration. Exploring details about dnp salary by specialty can guide students and professionals in making informed decisions about their educational investments and career goals within immunology and related fields.

Best Scientists Citing Robert H. Wiltrout

Trending Scientists